AwardedSpainGoods€35,857,587
Suministro de Humira® (Adalimumab) para la continuación de tratamientos excluyendo los nuevos tratamientos, Venetoclax (DOE) y Dexametasona (DOE) intravitrea
- Published
- Published 24 April 2026
Overview
Suministro de Humira® (Adalimumab) para la continuación de tratamientos excluyendo los nuevos tratamientos, Venetoclax (DOE) y Dexametasona (DOE) intravitrea
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Estimated value
- €35,857,587
- Procedure
- Direct
- Published
- 24 April 2026
Pharmaceutical products
Award outcome
- Awarded value
- €24,729,371
- Award date
- 21 April 2026
- Contract period
- — → 20 April 2030
- ABBVIE SPAIN, S.L.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
24 April 2026
Contracting authority
OSAKIDETZA - Servicio Vasco de Salud - Organización Central
Procuring entityVitoria-Gasteiz, Spain
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.